Celularity Reports Third Quarter 2022 Financial Results and
Announced first patient treated in Phase 1/2a clinical trial for CYNK-101 in first-line advanced HER2 positive gastric and gastroesophageal junction...
Stay updated with breaking news from Chief Technical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Announced first patient treated in Phase 1/2a clinical trial for CYNK-101 in first-line advanced HER2 positive gastric and gastroesophageal junction...
Intelsat has been chosen by MTN Group to further the company’s leadership while meeting the demand for broadband in remote areas of South Sudan.
Fisheries professional and Technical Advisor with more than 21 years of Industry Experience
/PRNewswire/ -- Shoreline Biosciences, Inc. (Shoreline), a biopharmaceutical company developing next-generation cellular immunotherapies based on induced...
/PRNewswire/ -- Zetaris, the leading analytical data virtualization company enabling real-time joined analysis of data across multiple clouds and the data...